Skip to menu Skip to content Skip to footer

2002

Journal Article

Erratum: Reduction of the accumulation of advanced glycation end products by ACE inhibition in experimental diabetic nephropathy (Diabetes (2000) 51 (3274-3282))

Forbes, J. M., Cooper, M. E., Thallas, V., Burns, W. C., Thomas, M. C., Brammar, G. C., Lee, F., Grant, S. L., Burrell, L. A., Jerums, G. and Osicka, T. M. (2002). Erratum: Reduction of the accumulation of advanced glycation end products by ACE inhibition in experimental diabetic nephropathy (Diabetes (2000) 51 (3274-3282)). Diabetes, 51 (12)

Erratum: Reduction of the accumulation of advanced glycation end products by ACE inhibition in experimental diabetic nephropathy (Diabetes (2000) 51 (3274-3282))

2002

Journal Article

Reduction of the accumulation of advanced glycation end products by ACE inhibition in experimental diabetic nephropathy

Forbes, Josephine M., Cooper, Mark E., Thallas, Vicki, Burns, Wendy C., Thomas, Merlin C., Brammar, Gail C., Lee, Fiona, Grant, Sharon L., Burrell, Louise M., Jerums, George and Osicka, Tanya M. (2002). Reduction of the accumulation of advanced glycation end products by ACE inhibition in experimental diabetic nephropathy. Diabetes, 51 (11), 3274-3282. doi: 10.2337/diabetes.51.11.3274

Reduction of the accumulation of advanced glycation end products by ACE inhibition in experimental diabetic nephropathy

2002

Conference Publication

Pivotal role of the AT2 receptor subtype in mediating angiotensin II indiced renal VEGF expression.

Rizkalla, BM, Cao, ZM, Forbes, JM and Cooper, ME (2002). Pivotal role of the AT2 receptor subtype in mediating angiotensin II indiced renal VEGF expression.. LIPPINCOTT WILLIAMS & WILKINS.

Pivotal role of the AT2 receptor subtype in mediating angiotensin II indiced renal VEGF expression.

2002

Conference Publication

Renoprotection is afforded by the advanced glycation end product (AGE) cross-link breaker, ALT-711.

Forbes, JM, Thallas, V, Jerums, G, Thomas, MC and Cooper, ME (2002). Renoprotection is afforded by the advanced glycation end product (AGE) cross-link breaker, ALT-711.. LIPPINCOTT WILLIAMS & WILKINS.

Renoprotection is afforded by the advanced glycation end product (AGE) cross-link breaker, ALT-711.

2002

Conference Publication

Expression of connective tissue growth factor in the diabetic kidney: association with renal collagen synthesis.

Cooper, ME, Cao, Z, Candido, R, Forbes, JM, Osicka, TM, Twigg, S and Bonnet, F (2002). Expression of connective tissue growth factor in the diabetic kidney: association with renal collagen synthesis.. 38th EASD Annual Meeting of the European-Association-for-the-Study-of-Diabetes, Budapest Hungary, Sep 01-05, 2002. SPRINGER-VERLAG.

Expression of connective tissue growth factor in the diabetic kidney: association with renal collagen synthesis.

2002

Conference Publication

Does combined blockade of RAS and advanced glycation end-product formation confer superior renoprotection in a hypertensive model of diabetic nephropathy?

Davis, BJ, Forbes, JM, Jerums, G, Cooper, ME and Allen, TJ (2002). Does combined blockade of RAS and advanced glycation end-product formation confer superior renoprotection in a hypertensive model of diabetic nephropathy?. 19th Meeting of the International-Society-for-Hypertension/12th European-Society-of-Hypertension Meeting, Prague Czech Republic, Jun 23-27, 2002. LIPPINCOTT WILLIAMS & WILKINS.

Does combined blockade of RAS and advanced glycation end-product formation confer superior renoprotection in a hypertensive model of diabetic nephropathy?

2002

Conference Publication

Renal connective tissue growth factor induction in experimental diabetes is prevented by aminoguanidine

Twigg, SM, Cao, Z, Burns, WC, Brammar, G, Forbes, JM and Cooper, ME (2002). Renal connective tissue growth factor induction in experimental diabetes is prevented by aminoguanidine. AMER DIABETES ASSOC.

Renal connective tissue growth factor induction in experimental diabetes is prevented by aminoguanidine

2002

Journal Article

Modulation of nephrin in the diabetic kidney: association with systemic hypertension and increasing albuminuria

Forbes, Josephine M., Bonnet, Fabrice, Russo, Leileata M., Burns, Wendy C., Cao, Zemin, Candido, Riccardo, Kawachi, Hiroshi, Allen, Terri J., Cooper, Mark E., Jerums, George and Osicka, Tanya M. (2002). Modulation of nephrin in the diabetic kidney: association with systemic hypertension and increasing albuminuria. Journal of Hypertension, 20 (5), 985-992. doi: 10.1097/00004872-200205000-00034

Modulation of nephrin in the diabetic kidney: association with systemic hypertension and increasing albuminuria

2001

Journal Article

Advanced glycation end products cause epithelial-myofibroblast transdifferentiation via the receptor for advanced glycation end products (RAGE)

Oldfield, MD, Bach, LA, Forbes, JM, Nikolic-Paterson, D, McRobert, A, Thallas, V, Atkins, RC, Osicka, T, Jerums, G and Cooper, ME (2001). Advanced glycation end products cause epithelial-myofibroblast transdifferentiation via the receptor for advanced glycation end products (RAGE). Journal of Clinical Investigation, 108 (12), 1853-1863. doi: 10.1172/jci11951

Advanced glycation end products cause epithelial-myofibroblast transdifferentiation via the receptor for advanced glycation end products (RAGE)

2001

Journal Article

Simultaneous blockade of endothelin A and B receptors in ischemic acute renal failure is detrimental to long-term kidney function

Forbes, Josephine Maree, Hewitson, Timothy David, Becker, Gavin James and Jones, Colin Lindsay (2001). Simultaneous blockade of endothelin A and B receptors in ischemic acute renal failure is detrimental to long-term kidney function. Kidney International, 59 (4), 1333-1341. doi: 10.1046/j.1523-1755.2001.0590041333.x

Simultaneous blockade of endothelin A and B receptors in ischemic acute renal failure is detrimental to long-term kidney function

2001

Journal Article

Endothelin and endothelin A/B receptors are increased after ischaemic acute renal failure

Forbes, JM, Jandeleit-Dahm, K, Allen, TJ, Hewitson, TD, Becker, GJ and Jones, CL (2001). Endothelin and endothelin A/B receptors are increased after ischaemic acute renal failure. Experimental Nephrology, 9 (5), 309-316.

Endothelin and endothelin A/B receptors are increased after ischaemic acute renal failure

2001

Journal Article

Renoprotective effects of a novel inhibitor of advanced glycation

Forbes, J. M., Soulis, T., Thallas, V., Panagiotopoulos, S., Long, D. M., Vasan, S., Wagle, D., Jerums, G. and Cooper, M. E. (2001). Renoprotective effects of a novel inhibitor of advanced glycation. Diabetologia, 44 (1), 108-114. doi: 10.1007/s001250051587

Renoprotective effects of a novel inhibitor of advanced glycation

2000

Journal Article

Ischemic acute renal failure: long-term histology of cell and matrix changes in the rat

Forbes, Josephine M., Hewitson, Timothy D., Becker, Gavin J. and Jones, Colin L. (2000). Ischemic acute renal failure: long-term histology of cell and matrix changes in the rat. Kidney International, 57 (6), 2375-2385. doi: 10.1046/j.1523-1755.2000.00097.x

Ischemic acute renal failure: long-term histology of cell and matrix changes in the rat

2000

Journal Article

Angiotensin type 2 receptor is expressed in the adult rat kidney and promotes cellular proliferation and apoptosis

Cao, ZM, Kelly, DJ, Cox, A, Casley, D, Forbes, JM, Martinello, P, Dean, R, Gilbert, RE and Cooper, ME (2000). Angiotensin type 2 receptor is expressed in the adult rat kidney and promotes cellular proliferation and apoptosis. Kidney International, 58 (6), 2437-2451. doi: 10.1046/j.1523-1755.2000.00427.x

Angiotensin type 2 receptor is expressed in the adult rat kidney and promotes cellular proliferation and apoptosis

2000

Journal Article

The cross-link breaker, N-phenacylthiazolium bromide prevents vascular advanced glycation end-product accumulation

Cooper, ME, Thallas, V, Forbes, J, Scalbert, E, Sastra, S, Darby, I and Soulis, T (2000). The cross-link breaker, N-phenacylthiazolium bromide prevents vascular advanced glycation end-product accumulation. Diabetologia, 43 (5), 660-664. doi: 10.1007/s001250051355

The cross-link breaker, N-phenacylthiazolium bromide prevents vascular advanced glycation end-product accumulation

1999

Journal Article

Macrophage and myofibroblast involvement in ischemic acute renal failure is attenuated by endothelin receptor antagonists

Forbes, Josephine M., Leaker, Brian, Hewitson, Tim D., Becker, Gavin J. and Jones, Colin L. (1999). Macrophage and myofibroblast involvement in ischemic acute renal failure is attenuated by endothelin receptor antagonists. Kidney International, 55 (1), 198-208. doi: 10.1046/j.1523-1755.1999.00253.x

Macrophage and myofibroblast involvement in ischemic acute renal failure is attenuated by endothelin receptor antagonists

1997

Conference Publication

Artificial activation of matrix metalloproteinases.

Jones, CI, Forbes, JM, Walker, RG and Becker, GJ (1997). Artificial activation of matrix metalloproteinases.. BLACKWELL SCIENCE INC.

Artificial activation of matrix metalloproteinases.

1996

Conference Publication

Activation of renal type IV collagenases.

Jones, CL, Forbes, JM, Walker, RG and Becker, GJ (1996). Activation of renal type IV collagenases.. AMER SOC NEPHROLOGY.

Activation of renal type IV collagenases.

1995

Journal Article

Tissue Inhibitor of the Metalloproteinases and Renal Extracellular-Matrix Accumulation

Jones, CL, Fecondo, J, Kelynack, K, Forbes, J, Walker, R and Becker, G (1995). Tissue Inhibitor of the Metalloproteinases and Renal Extracellular-Matrix Accumulation. Experimental Nephrology, 3 (2), 80-86.

Tissue Inhibitor of the Metalloproteinases and Renal Extracellular-Matrix Accumulation